Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2016 Volume 14 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2016 Volume 14 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes

Corrigendum in: /10.3892/mmr.2020.10919
  • Authors:
    • Shuya Wang
    • Ying Li
    • Wei Miao
    • Hong Zhao
    • Feng Zhang
    • Nan Liu
    • Guohai Su
    • Xiaojun Cai
  • View Affiliations / Copyright

    Affiliations: Department of Cardiovascular Medicine, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2607-2613
    |
    Published online on: July 25, 2016
       https://doi.org/10.3892/mmr.2016.5544
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to determine the inhibitory effects of angiotensin II (AngII) on angiopoietin‑like protein 2 (Angptl2) in rat primary cardiomyocytes, and to investigate the potential association between angiotensin II type 1 receptor (AT1R) and these effects. Cardiomyocytes were isolated from 3-day-old Wistar rats, and were cultured and identified. Subsequently, the expression levels of Angptl2 were detected following incubation with various concentrations of AngII for various durations using western blotting, reverse transcription‑quantitative polymerase chain reaction, enzyme-linked immunosorbent assay and immunofluorescence. Finally, under the most appropriate conditions (100 nmol/l AngII, 24 h), the cardiomyocytes were divided into six groups: Normal, AngII, AngII + losartan, normal + losartan, AngII + PD123319 and normal + PD123319 groups, in order to investigate the possible function of AT1R in Angptl2 suppression. Losartan and PD123319 are antagonists of AT1R and angiotensin II type 2 receptor, respectively. The statistical significance of the results was analyzed using Student's t‑test or one‑way analysis of variance. The results demonstrated that Angptl2 expression was evidently suppressed (P<0.05) following incubation with 100 nmol/l AngII for 24 h. Conversely, the expression levels of Angptl2 were significantly increased in the AngII + losartan group compared with the AngII group (P<0.01). However, no significant difference was detected between the AngII + PD123319, normal + losartan or normal + PD123319 groups and the normal group. The present in vitro study indicated that AngII was able to suppress Angptl2 expression, whereas losartan was able to significantly reverse this decrease by inhibiting AT1R.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Cai Y, Wang Y, Xu J, Zuo X and Xu Y: Down-regulation of ether-a-go-go-related gene potassium channel protein through sustained stimulation of AT1 receptor by angiotensin II. Biochem Biophys Res Commun. 452:852–857. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Welter H, Huber A, Lauf S, Einwang D, Mayer C, Schwarzer JU, Köhn FM and Mayerhofer A: Angiotensin II regulates testicular peritubular cell function via AT1 receptor: A specific situation in male infertility. Mol Cell Endocrinol. 393:171–178. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Matsoukas MT, Potamitis C, Plotas P, Androutsou ME, Agelis G, Matsoukas J and Zoumpoulakis P: Insights into AT1 receptor activation through AngII binding studies. J Chem Inf Model. 53:2798–2811. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Reid IA: Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 262:E763–E778. 1992.PubMed/NCBI

5 

Siragy HM: AT(1) and AT(2) receptors in the kidney: Role in disease and treatment. Am J Kidney Dis. 36(3 Suppl 1): S4–S9. 2000. View Article : Google Scholar : PubMed/NCBI

6 

Schmieder RE, Hilgers KF, Schlaich MP and Schmidt BM: Renin-angiotensin system and cardiovascular risk. Lancet. 369:1208–1219. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Messerli FH, Weber MA and Brunner HR: Angiotensin II receptor inhibition. A new therapeutic principle. Arch Intern Med. 156:1957–1965. 1996. View Article : Google Scholar : PubMed/NCBI

8 

Goodfriend TL, Elliott ME and Catt KJ: Angiotensin receptors and their antagonists. N Engl J Med. 334:1649–1654. 1996. View Article : Google Scholar : PubMed/NCBI

9 

Doblinger E, Höcherl K, Mederle K, Kattler V, Walter S, Hansen PB, Jensen B and Castrop H: Angiotensin AT1 receptor-associated protein Arap1 in the kidney vasculature is suppressed by angiotensin II. Am J Physiol Renal Physiol. 302:F1313–F1324. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Kim SS, Choi IG, Kim SH and Yu YG: Molecular cloning, expression, and characterization of a thermostable glutamate racemase from a hyperthermophilic bacterium, Aquifex pyrophilus. Extremophiles. 3:175–183. 1999. View Article : Google Scholar : PubMed/NCBI

11 

Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, Urano T, Zhu HJ, Tsukano H, Tazume H, et al: Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab. 10:178–188. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Kadomatsu T, Tabata M and Oike Y: Angiopoietin-like proteins: Emerging targets for treatment of obesity and related metabolic diseases. FEBS J. 278:559–564. 2011. View Article : Google Scholar

13 

Guo DF, Chenier I, Tardif V, Orlov SN and Inagami T: Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane. Biochem Biophys Res Commun. 310:1254–1265. 2003. View Article : Google Scholar : PubMed/NCBI

14 

Matsui H, Yokoyama T, Tanaka C, Sunaga H, Koitabashi N, Takizawa T, Arai M and Kurabayashi M: Pressure mediated hypertrophy and mechanical stretch up-regulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes. BMC Cell Biol. 13:372012. View Article : Google Scholar : PubMed/NCBI

15 

Tao T, Wang X, Liu M and Liu X: Myofibrillogenesis regulator-1 attenuates hypoxia/reoxygenation-induced injury by repairing microfilaments in neonatal rat cardiomyocytes. Exp Cell Res. 337:234–242. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Cao T, Gao Z, Gu L, Chen M, Yang B, Cao K, Huang H and Li M: AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts. PLoS One. 9:e1037932014. View Article : Google Scholar : PubMed/NCBI

17 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar

18 

Oka T, Akazawa H, Naito AT and Komuro I: Angiogenesis and cardiac hypertrophy: Maintenance of cardiac function and causative roles in heart failure. Circ Res. 114:565–571. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Serneri GG, Boddi M, Cecioni I, Vanni S, Coppo M, Papa ML, Bandinelli B, Bertolozzi I, Polidori G, Toscano T, et al: Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function. Circ Res. 88:961–968. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Guo DF, Chenier I, Lavoie JL, Chan JS, Hamet P, Tremblay J, Chen XM, Wang DH and Inagami T: Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension. 48:453–459. 2006. View Article : Google Scholar : PubMed/NCBI

21 

Huang CL, Wu YW, Wu CC, Hwang JJ and Yang WS: Serum Angiopoietin-like protein 2 concentrations are independently associated with heart failure. PLoS One. 10:e01386782015. View Article : Google Scholar : PubMed/NCBI

22 

Thorin-Trescases N and Thorin E: Angiopoietin-like-2: A multifaceted protein with physiological and pathophysiological properties. Expert Rev Mol Med. 16:e172014. View Article : Google Scholar : PubMed/NCBI

23 

Farhat N, Thorin-Trescases N, Mamarbachi M, Villeneuve L, Yu C, Martel C, Duquette N, Gayda M, Nigam A, Juneau M, et al: Angiopoietin-like 2 promotes atherogenesis in mice. J Am Heart Assoc. 2:e0002012013. View Article : Google Scholar : PubMed/NCBI

24 

Ali MS, Sayeski PP, Dirksen LB, Hayzer DJ, Marrero MB and Bernstein KE: Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. J Biol Chem. 272:23382–23388. 1997. View Article : Google Scholar : PubMed/NCBI

25 

Sano T, Ohyama K, Yamano Y, Nakagomi Y, Nakazawa S, Kikyo M, Shirai H, Blank JS, Exton JH and Inagami T: A domain for G protein coupling in carboxyl-terminal tail of rat angiotensin II receptor type 1A. J Biol Chem. 272:23631–23636. 1997. View Article : Google Scholar : PubMed/NCBI

26 

Venema RC, Ju H, Venema VJ, Schieffer B, Harp JB, Ling BN, Eaton DC and Marrero MB: Angiotensin II-induced association of phospholipase Cgamma1 with the G-protein-coupled AT1 receptor. J Biol Chem. 273:7703–7708. 1998. View Article : Google Scholar : PubMed/NCBI

27 

Smith RD, Hunyady L, Olivares-Reyes JA, Mihalik B, Jayadev S and Catt KJ: Agonist-induced phosphorylation of the angiotensin AT1a receptor is localized to a serine/threonine-rich region of its cytoplasmic tail. Mol Pharmacol. 54:935–941. 1998.PubMed/NCBI

28 

Smith RD, Baukal AJ, Zolyomi A, Gaborik Z, Hunyady L, Sun L, Zhang M, Chen HC and Catt KJ: Agonist-induced phosphorylation of the endogenous AT1 angiotensin receptor in bovine adrenal glomerulosa cells. Mol Endocrinol. 12:634–644. 1998. View Article : Google Scholar : PubMed/NCBI

29 

Chaki S, Guo DF, Yamano Y, Ohyama K, Tani M, Mizukoshi M, Shirai H and Inagami T: Role of carboxyl tail of the rat angiotensin II type 1A receptor in agonist-induced internalization of the receptor. Kidney Int. 46:1492–1495. 1994. View Article : Google Scholar : PubMed/NCBI

30 

Hunyady L, Bor M, Balla T and Catt KJ: Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. J Biol Chem. 269:31378–31382. 1994.PubMed/NCBI

31 

Castrop H: Angiotensin receptor-associated proteins: Local modulators of the renin-angiotensin system. Pflugers Arch. 465:111–119. 2013. View Article : Google Scholar

32 

Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD and Eguchi S: Angiotensin II signal transduction through the AT1 receptor: Novel insights into mechanisms and pathophysiology. Clin Sci (Lond). 112:417–428. 2007. View Article : Google Scholar

33 

Mederle K, Schweda F, Kattler V, Doblinger E, Miyata K, Höcherl K, Oike Y and Castrop H: The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Crit Care. 17:R1302013. View Article : Google Scholar : PubMed/NCBI

34 

Guo DF, Sun YL, Hamet P and Inagami T: The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res. 11:165–180. 2001. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang S, Li Y, Miao W, Zhao H, Zhang F, Liu N, Su G and Cai X: Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes Corrigendum in /10.3892/mmr.2020.10919. Mol Med Rep 14: 2607-2613, 2016.
APA
Wang, S., Li, Y., Miao, W., Zhao, H., Zhang, F., Liu, N. ... Cai, X. (2016). Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes Corrigendum in /10.3892/mmr.2020.10919. Molecular Medicine Reports, 14, 2607-2613. https://doi.org/10.3892/mmr.2016.5544
MLA
Wang, S., Li, Y., Miao, W., Zhao, H., Zhang, F., Liu, N., Su, G., Cai, X."Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes Corrigendum in /10.3892/mmr.2020.10919". Molecular Medicine Reports 14.3 (2016): 2607-2613.
Chicago
Wang, S., Li, Y., Miao, W., Zhao, H., Zhang, F., Liu, N., Su, G., Cai, X."Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes Corrigendum in /10.3892/mmr.2020.10919". Molecular Medicine Reports 14, no. 3 (2016): 2607-2613. https://doi.org/10.3892/mmr.2016.5544
Copy and paste a formatted citation
x
Spandidos Publications style
Wang S, Li Y, Miao W, Zhao H, Zhang F, Liu N, Su G and Cai X: Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes Corrigendum in /10.3892/mmr.2020.10919. Mol Med Rep 14: 2607-2613, 2016.
APA
Wang, S., Li, Y., Miao, W., Zhao, H., Zhang, F., Liu, N. ... Cai, X. (2016). Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes Corrigendum in /10.3892/mmr.2020.10919. Molecular Medicine Reports, 14, 2607-2613. https://doi.org/10.3892/mmr.2016.5544
MLA
Wang, S., Li, Y., Miao, W., Zhao, H., Zhang, F., Liu, N., Su, G., Cai, X."Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes Corrigendum in /10.3892/mmr.2020.10919". Molecular Medicine Reports 14.3 (2016): 2607-2613.
Chicago
Wang, S., Li, Y., Miao, W., Zhao, H., Zhang, F., Liu, N., Su, G., Cai, X."Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes Corrigendum in /10.3892/mmr.2020.10919". Molecular Medicine Reports 14, no. 3 (2016): 2607-2613. https://doi.org/10.3892/mmr.2016.5544
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team